Strata Critical Medical, Inc. (SRTA): Cost of Revenue
$156.01M
Year ended 2025-12-31
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $156.01M | +33.1% | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | $117.23M | n/c | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | $183.06M | +47.8% | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | $123.84M | n/a | 2024-03-12, From 2022-01-01 |
| No annual figure between 2021-09-30 and 2022-12-31. | |||
| 2021-09-30 | $40.01M | +89.5% | 2023-03-16, From 2020-10-01 |
| 2020-09-30 | $21.11M | -20.3% | 2021-12-20, From 2019-10-01 |
| 2019-09-30 | $26.50M | n/a | 2021-12-20, From 2018-10-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Strata Critical Medical, Inc. (SRTA) | 2025-12-31 | $156.01M | +33.1% |
| Omada Health, Inc. (OMDA) | 2025-12-31 | $89.27M | +33.4% |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $129.37M | +16.5% |
| Vsee Health, Inc. (VSEE) | 2025-12-31 | $7.26M | +123.9% |
| EUDA Health Holdings Ltd (EUDA) | 2025-12-31 | $3.83M | +17.8% |
| Longduoduo Co Ltd (LDDD) | 2026-06-30 | $17.0K | -81.4% |
| Agape ATP Corp (ATPC) | 2025-12-31 | $686.0K | +21.7% |
Compare SRTA, OMDA, WGS, VSEE side by side · Screen every company in Services-Health Services ↗